| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $16.2B | $17.7B | $17.6B | $24.7B | $23.1B | $16.2B | $3.8B | $4.1B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | $0.8B | $0.7B | $0.5B | $1.3B | $1.1B | $0.7B | $0.1B | $0.3B |
| Net Income | $0.6B | $0.5B | $0.3B | $0.9B | $0.8B | $0.5B | $0.1B | $0.2B |
| EPS (Basic) | $4.88 | $3.89 | $2.74 | $7.48 | $6.37 | $3.74 | $0.73 | $1.36 |
| EPS (Diluted) | $4.83 | $3.86 | $2.72 | $7.40 | $6.31 | $3.72 | $0.73 | $1.34 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $5.1B | $5.3B | $5.2B | $6.0B | $7.0B | $5.1B | $4.6B | $4.4B |
| Current Assets | $2.8B | $3.0B | $2.9B | $3.6B | $4.8B | $2.9B | $2.6B | $2.8B |
| Cash & Equivalents | $0.2B | $0.1B | $0.1B | $0.2B | $0.3B | $0.2B | $0.4B | $0.4B |
| Total Liabilities | $3.2B | $3.6B | $3.8B | $4.6B | $5.0B | $3.3B | $3.0B | $2.8B |
| Current Liabilities | $1.8B | $2.3B | $2.1B | $3.3B | $3.3B | $1.8B | $1.6B | $1.4B |
| Stockholders' Equity | $1.8B | $1.7B | $1.4B | $1.4B | $2.0B | $1.9B | $1.7B | $1.6B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.9B | $0.5B | $0.7B | $1.7B | $0.1B | $0.5B | $0.8B | $0.8B |
| Investing Cash Flow | $-0.1B | $-0.1B | $-0.1B | $-0.1B | $-0.1B | $-0.3B | $-0.1B | $-0.1B |
| Capital Expenditures | $0.0B | $0.0B | $0.0B | $0.1B | $0.0B | $0.0B | $0.0B | $0.0B |
| Financing Cash Flow | $-0.9B | $-0.4B | $-0.7B | $-1.6B | $0.0B | $-0.4B | $-0.7B | $-0.7B |